Jabil (JBL) Is Attractively Priced Despite Fast-paced Momentum — Positive
JBL Zacks Investment Research — December 22, 2025If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Jabil (JBL) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Despite Fast-paced Momentum, American Eagle (AEO) Is Still a Bargain Stock — Positive
AEO Zacks Investment Research — December 22, 2025American Eagle (AEO) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Janus Henderson to Be Bought by Trian and General Catalyst for $7.4 Billion — Positive
JHG WSJ — December 22, 2025Janus Henderson has agreed to a takeover by investment firms Trian Fund Management and General Catalyst valuing the asset manager at roughly $7.4 billion.
AVTR INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Avantor — Neutral
AVTR Newsfile Corp — December 22, 2025Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered in Avantor to Contact Him Directly to Discuss Their Options If you purchased or acquired securities in Avantor between March 5, 2024 and October 28, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - December 22, 2025) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Avantor, Inc. ("Avantor" or the …
Pension dispute could prolong strike at Brazil's Petrobras — Negative
PBR PBR-A Reuters — December 22, 2025A dispute involving about 50,000 retired Petrobras employees over payment deductions may prolong a strike at the Brazilian state-run oil firm, union leaders and executives told Reuters.
Ventas Stock Rallies 24.5% in Six Months: Will the Trend Last? — Positive
VTR Zacks Investment Research — December 22, 2025VTR shares rise 24.5% in six months, far outperforming the industry, as strong SHOP growth and balance sheet gains lift sentiment.
Union Pacific, Norfolk Southern merger faces pushback from signalmen's union — Negative
NSC UNP Reuters — December 22, 2025A rail workers' union on Monday opposed Union Pacific's proposed $85 billion acquisition of Norfolk Southern , warning that the deal could undermine safety and impact the workforce.
NESR Becomes First Oilfield Services Company to Commission Original Artwork Created from Recycled Produced Water — Neutral
NESR Accesswire — December 22, 2025Landmark collaboration highlights how energy, art and sustainability can converge to redefine environmental stewardship DUBAI, UAE / ACCESS Newswire / December 22, 2025 / National Energy Services Reunited Corp. ("NESR" or the "Company") (Nasdaq:NESR), an international, industry-leading provider of integrated energy services in the Middle East and North Africa ("MENA") region, has become the first oilfield services company to commission original artwork created using desalinated produced water recycled through its sustainability arm, Environmental & Decarbonization Applications ("NEDA"). The initiative titled "It Starts with Us" was unveiled during NESR's press night in Dubai and underscores the Company's commitment to advancing environmental …
INSP INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Inspire Medical Systems — Neutral
INSP Newsfile Corp — December 22, 2025Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses in Inspire Medical to Contact Him Directly to Discuss Their Options If you purchased or acquired securities in Inspire Medical between August 6, 2024 and August 4, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - December 22, 2025) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Inspire Medical …
AVTR Investors Have Opportunity to Lead Avantor, Inc. Securities Fraud Lawsuit with the Schall Law Firm — Neutral
AVTR GlobeNewsWire — December 22, 2025LOS ANGELES, Dec. 22, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Avantor, Inc. (“Avantor” or “the Company”) (NYSE: AVTR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between March 5, 2024, and October 28, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before December 29, 2025.
Cytokinetics, Incorporated (CYTK) Discusses FDA Approval of MYQORZO for Symptomatic Obstructive Hypertrophic Cardiomyopathy Transcript — Neutral
CYTK Seeking Alpha — December 22, 2025Cytokinetics, Incorporated (CYTK) Discusses FDA Approval of MYQORZO for Symptomatic Obstructive Hypertrophic Cardiomyopathy Transcript
Janus Henderson Stock Surges. The Asset Manager Is Being Taken Private in $7.4 Billion Deal. — Positive
JHG Barrons — December 22, 2025Nelson Peltz's Trian Fund Management and General Catalyst Group Management will acquire Janus Henderson in an all-cash deal worth $49 a share.
Intuitive Machines Outlook: KeyBanc Rating, Acquisition Upside, And 3-Year Breakeven — Positive
LUNR Seeking Alpha — December 22, 2025Intuitive Machines, Inc. is Buy-rated, with significant upside tied to the $800M Lanteris Space Systems acquisition and defense sector tailwinds expected in 2026. LUNR's pro-forma annual revenue is projected to exceed $850M, with backlog expanding to $920M and a robust $622M cash balance supporting liquidity. Valuation is stretched at 7.3x TTM price-to-sales, but integration synergies and Lanteris' higher-margin contracts could drive breakeven EBITDA within three years.
Instacart ends AI-driven pricing tests that drove up costs for some shoppers — Negative
CART CNBC — December 22, 2025Instacart said it will no longer allow retailers to run AI pricing tests on its grocery delivery platform after the practice drew widespread scrutiny. A study released earlier this month showed that Instacart's algorithmic pricing tools caused shoppers to pay different prices for identical items from the same store.
HSBC appoints ex-Citi executive Ida Liu to lead private bank — Neutral
C HSBC Reuters — December 22, 2025HSBC said on Monday it appointed Ida Liu as chief executive officer of HSBC's private bank, effective January 5.
3 Ways to Actively Get More Fixed Income in 2026 — Positive
VCRM VPLS ETF Trends — December 22, 2025Record demand and new launches have helped to define a banner year for fixed income in 2025. With 2026 around the corner, it's an ideal time to explore the best ways to maximize fixed income exposure as the Fed continues easing monetary policy.
Nelson Peltz's Trian and General Catalyst to Buy Janus Henderson for $7.4 Billion — Positive
JHG Bloomberg Markets and Finance — December 22, 2025Nelson Peltz's Trian Fund Management and General Catalyst agreed to buy asset manager Janus Henderson Group Plc for about $7.4 billion. Kristine Aquino has more on "Bloomberg Open Interest.
Instacart ends AI-driven price experiments after criticism — Negative
CART Reuters — December 22, 2025Instacart is ending price tests that resulted in different shoppers being shown different prices for groceries, the online retail platform said on Monday after criticism of its artificial intelligence-driven pricing tool.
MIMEDX Enters into Exclusive U.S. Distribution Agreement for RegenKit®-Wound Gel — Neutral
MDXG GlobeNewsWire — December 22, 2025MARIETTA, Ga., Dec. 22, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced it has entered into an exclusive agreement with Regen Lab USA LLC to distribute their RegenKit®-Wound Gel in the United States.